Status:
COMPLETED
Consistency Lots Vaccine Study (V260-009)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Rotavirus Infections
Eligibility:
All Genders
6-12 years
Phase:
PHASE3
Brief Summary
This study was designed to evaluate consistency in the antibody response to three manufactured lots of an investigational Rotavirus Vaccine.
Eligibility Criteria
Inclusion
- Healthy infants
Exclusion
- History of abdominal disorders from a birth defect, intussusception, or abdominal surgery
- Known or suspected problems with the immune system
- Fever at time of immunization
- Prior administration of a rotavirus vaccine
- History of known prior rotavirus disease, chronic diarrhea, or failure to thrive.
Key Trial Info
Start Date :
May 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2004
Estimated Enrollment :
793 Patients enrolled
Trial Details
Trial ID
NCT00092456
Start Date
May 1 2003
End Date
August 1 2004
Last Update
October 5 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.